Paclitaxel with Encequidar for advanced breast cancer

Oral paclitaxel with encequidar is in clinical development for advanced breast cancer. Advanced breast cancer is a type of breast cancer that has spread to another part of the body. Survival outcomes for patients with advanced breast cancer are poor and current chemotherapy options, including intravenous (IV) administration of paclitaxel, are associated with adverse side effects. Therefore, there is a need for additional therapies for these patients.